SystImmune Patents – Insights & Stats (Updated 2023)

SystImmune has a total of 246 patents globally, out of which 36 have been granted. Of these 246 patents, more than 89% patents are active. China is where SystImmune has filed the maximum number of patents, followed by United States of America and Japan. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of SystImmune.

SystImmune was founded in 2014. SystImmune is a biotechnology company which develops therapies for inflammatory diseases and life-threatening toxicities.

Do read about some of the most popular patents of SystImmune which have been covered by us in this article and also you can find SystImmune patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over SystImmune patent portfolio.

How many patents does SystImmune have?

SystImmune has a total of 246 patents globally. These patents belong to 10 unique patent families. Out of 246 patents, 219 patents are active.

How Many Patents did SystImmune File Every Year?

SystImmune Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantSystImmune Applications FiledSystImmune Patents Granted
20231123
202297
2021663
2020161
2019302
201883
20172
201529

How many SystImmune patents are Active/Inactive?

Worldwide Patents

SystImmune Patent Portfolio

How Many Patents did SystImmune File in Different Countries?

SystImmune Worldwide Patent Filing

Countries in which SystImmune Filed Patents

CountryPatent
China40
United States Of America22
Japan22
Europe19
Taiwan14
Hong Kong (S.A.R.)14
Israel13
Singapore12
South Korea12
Canada11
Australia10
New Zealand8
India8
Russia7
Mexico4
Brazil4
Italy1

Where are Research Centers of SystImmune Patents Located?

The Research Centers of SystImmune are located in the United States of America.

10 Best SystImmune Patents

WO2019005641A1 is the most popular patent in the SystImmune portfolio. It has received 18 citations so far from companies like Elstar Therapeutics, Myeloid Therapeutics and Pionyr Immunotherapeutics.

Below is the list of 10 most cited patents of SystImmune:

Publication NumberCitation Count
WO2019005641A118
WO2019191120A110
WO2019005636A28
WO2016106158A16
WO2016106157A16
US20210024630A15
WO2019090002A14
WO2019005634A24
WO2019005635A24
WO2019005638A24

What Percentage of SystImmune US Patent Applications Were Granted?

SystImmune (Excluding its subsidiaries) has filed 17 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 8 have been granted leading to a grant rate of 88.89%.

Below are the key stats of SystImmune patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for SystImmune?

Law FirmTotal ApplicationsSuccess Rate
Epimed Llc        1788.89%

What are SystImmune key innovation segments?

What Technologies are Covered by SystImmune?

The chart below distributes patents filed by SystImmune in different countries on the basis of the technology protected in patents. It also represents the markets where SystImmune thinks it’s important to protect particular technology inventions.

R&D Focus: How has SystImmune search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by SystImmune?

Related Articles

Computime Patents – Insights & Stats (Updated 2024)

Computime has a total of 224 patents globally, out of which 115 have been granted. Of these 224 patents, more than 63% patents are active. The United States of America is where Computime has filed the maximum number of patents, followed by Europe (EPO) and Germany. Parallelly, United States of

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.